Search Results 781-790 of 19856 for Hepatitis b

1. Use Of F-652 In Patients With Alcoholic Hepatitis - Mayo Clinic

   About this study. Alcoholic hepatitis is a syndrome of progressive inflammatory liver injury associated with long-term heavy intake of ethanol.

2. Dr. Mody 02-22-2021 - Mayo Clinic News Network

   Alcohol consumption can raise the risk for cholangiocarcinoma by about two to three times in retrospective looks. Chronic hepatitis C and chronic hepatitis B, ...

3. FT819 in Subjects With B-cell Malignancies - Mayo Clinic

   Positive serologic and polymerase chain reaction (PCR) test results for Hepatitis B (HBV) infection. Positive serologic and PCR test results for Hepatitis C ( ...

4. Acoramidis Transthyretin Amyloidosis Prevention Trial In The Young (ACT-EARLY) Study In Asymptomatic Carriers Of A Pathogenic TTR Variant - Mayo Clinic

   * Other diseases or conditions such has cancer within 3 years, untreated hyperthyroidism or hypothyroidism, type 1 diabetes, active hepatitis B or C, HIV.

5. Primary biliary cholangitis (PBC) - Doctors and departments - Mayo Clinic

   ... Hepatitis C, Hepatitis B, Primary biliary cholangitis, Pr...imary sclerosing cholangitis, Wilson's disease, Portal hypertension, Autoimmune hepatitis ...

6. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   ... hepatitis B will be excluded unless the following criteria can be met: - If patient's serology shows hepatitis B virus core antibody (HbcAb)+ and hepatitis B ...

7. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   Participation eligibility · Patients with a positive hepatitis B core antibody but with negative hepatitis B DNA may participate, but must have hepatitis ...

8. A Study of STRO-001 in Patients with Advanced B-Cell Malignancies - Mayo Clinic

   Positive serology for hepatitis B defined by a positive test for HBsAg. Concurrent participation in another therapeutic treatment trial. High screening ...

9. GATE1: A Multicenter Phase II Study Of Pirtobrutinib, Rituximab And Venetoclax Combination Therapy For Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

   * Hepatitis B virus (HBV): Patients with positive hepatitis B surface antigen (HBsAg) are excluded. Patients with positive hepatitis B core antibody (anti ...

10. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... hepatitis B surface antigen [HBsAg] serology). Patients with occult or prior hepatitis B infection (defined as positive total hepatitis B core antibody ...